A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy

Canadian Journal of Anaesthesia

Volumn 43, Issue 5, 1996, Pages 442-449

  Finucane, Brendan T ^a   Sandler, Alan N ^b   McKenna, Jocelyne ^b   Reid, Dennis ^b   Milner, Anna Lee ^b   Friedlander, Mark ^b   Muzyka, David ^b   O'Callaghan Enright, Sheila ^b   Chan, Vincent ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b NONE

Author keywords

Anaesthetic techniques: epidural; Anaesthetics local: ropivacaine, bupivacaine; Surgery: gynaecology

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EPIDURAL ANESTHESIA; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029891324     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018104     Document Type: Article

References (12)

1. Ekenstam B, Egnér B, Pettersson G. Local Anaesthetic I. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic acid amides. Acta Chem Scand 1957; 11: 1183-90.
2. Rosenberg PH, Kyttä J, Alila A. Absorption of bupivacaine, etidocaine, lignocaine and ropivacaine into N-heptane, rat sciatic nerve, and human extradural and subcutaneous fat. Br J Anaesth 1986; 58: 310-4.
3. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine (Editorial). Anesthesiology 1979; 51: 285-7.
4. Reiz S, Häggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine - a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93-8.
5. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69: 794-801.
6. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg 1989; 69: 276-83.
7. Rutten AJ, Nancarrow C, Mather LE, Ilsley AH, Runciman WB, Upton RN. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 1989; 69: 291-9.
8. Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine with that of bupivacaine. Anesth Analg 1989; 69: 563-9.
9. Bader AM, Datta S, Flanagan H, Covino BG. Comparison of bupivacaine- and ropivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg 1989; 68: 724-7.
10. Akerman B, Hellberg I-B, Trossvik C. Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571-8.
11. Brockway MS, Bannister J, McClure JH, McKeown D, Wildsmith JAW. Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31-7.
12. Wolff AP, Hasselström L, Kerkkamp HE, Gielen MJ. Extradural ropivacaine and bupivacaine in hip surgery. Br J Anaesth 1995; 74: 458-60.